Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2012 Jun 6:12:57.
doi: 10.1186/1471-244X-12-57.

The Depression in Visual Impairment Trial (DEPVIT): trial design and protocol

Randomized Controlled Trial

The Depression in Visual Impairment Trial (DEPVIT): trial design and protocol

Tom H Margrain et al. BMC Psychiatry. .

Abstract

Background: The prevalence of depression in people with a visual disability is high but screening for depression and referral for treatment is not yet an integral part of visual rehabilitation service provision. One reason for this may be that there is no good evidence about the effectiveness of treatments in this patient group. This study is the first to evaluate the effect of depression treatments on people with a visual impairment and co morbid depression.

Methods /design: The study is an exploratory, multicentre, individually randomised waiting list controlled trial. Participants will be randomised to receive Problem Solving Therapy (PST), a 'referral to the GP' requesting treatment according to the NICE's 'stepped care' recommendations or the waiting list arm of the trial. The primary outcome measure is change (from randomisation) in depressive symptoms as measured by the Beck's Depression Inventory (BDI-II) at 6 months. Secondary outcomes include change in depressive symptoms at 3 months, change in visual function as measured with the near vision subscale of the VFQ-48 and 7 item NEI-VFQ at 3 and 6 months, change in generic health related quality of life (EQ5D), the costs associated with PST, estimates of incremental cost effectiveness, and recruitment rate estimation.

Discussion: Depression is prevalent in people with disabling visual impairment. This exploratory study will establish depression screening and referral for treatment in visual rehabilitation clinics in the UK. It will be the first to explore the efficacy of PST and the effectiveness of NICE's 'stepped care' approach to the treatment of depression in people with a visual impairment.

Trial registration: ISRCTN46824140.

PubMed Disclaimer

Figures

Figure 1
Figure 1
DEPVIT Trial Design.

References

    1. Osborn DPJ, Fletcher AE, Smeeth L, Stirling S, Bulpitt CJ, Breeze E, Ng ESW, Nunes M, Jones D, Tulloch A. Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry. 2003;18(7):623–630. doi: 10.1002/gps.896. - DOI - PubMed
    1. Waern M, Rubenowitz E, Runeson B, Skoog I, Wilhelmson K, Allebeck P. Burden of illness and suicide in elderly people: case–control study. Br Med J. 2002;324(7350):1355–1357. doi: 10.1136/bmj.324.7350.1355. - DOI - PMC - PubMed
    1. Evans JR, Fletcher AE, Wormald RPL. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–288. doi: 10.1016/j.ophtha.2006.10.006. - DOI - PubMed
    1. Brody BL, Gamst AC, Williams RA, Smith AR, Lau PW, Dolnak D, Rapaport MH, Kaplan RM, Brown SI. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology. 2001;108(10):1893–1900. doi: 10.1016/S0161-6420(01)00754-0. - DOI - PubMed
    1. Brody BL, Roch-Levecq AC, Thomas RG, Kaplan RM, Brown SI. Self-management of age-related macular degeneration at the 6-month follow-up - A randomized controlled trial. Arch Ophthalmol. 2005;123(1):46–53. doi: 10.1001/archopht.123.1.46. - DOI - PubMed

Publication types

MeSH terms

Associated data